平衡出血和凝块:在患有腹腔内血瘤的患者中,二型肝素诱导的血栓缺血与广泛的血栓形成
George K Annan1, Enoch Enninful2, Chinenye Egwuonwu1
1Internal Medicine, Piedmont Athens Regional Medical Center, Athens, USA.
Cureus
|December 26, 2025
概括
本案例研究详细介绍了在患有内出血的老年患者中治疗2型肝素诱导的血小板缩 (HIT) 的方法. 它强调了阿斯巴特罗班和阿皮克萨班作为安全的抗凝药选择,强调为复杂病例提供量身定制的护理.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 关键护理医学 关键护理医学
背景情况:
- 肝素诱导的血小板缺血 (HIT) 2型是肝素治疗的严重免疫并发症.
- 它涉及对血小板因子4 (PF4) /肝素复合体的抗体,导致血小板缺血和血栓形成.
- 管理HIT类型2是复杂的,特别是同时出血,如内出血.
研究的目的:
- 在患有内出血和基本血栓细胞血症的患者中呈现HIT类型2病例.
- 讨论在这样复杂的场景中抗凝药的挑战和治疗策略.
- 突出阿格拉斯罗班和直接口服抗凝剂 (DOACs) 在管理出血风险的HIT中的作用.
主要方法:
- 一个病例报告,是一名87岁的男性患有基本血小板血和心房动.
- 患者患上了皮下血液瘤,深静脉血栓和肺栓塞.
- 通过PF4 ELISA和血清素释放试验证实了HIT 2型的诊断;治疗涉及了 argatroban 和 apixaban.
主要成果:
- 患者经历了多次血栓事件,尽管最初的抗凝治疗管理.
- 证实了HIT类型2的确诊,需要切换到阿斯拉特罗班,然后再到阿皮克萨班.
- 神经稳定性得到维持,并通过量身定制的管理实现了有利的结果.
结论:
- 管理HIT类型2与活跃的内出血呈现出一个重要的治疗困境.
- 由于其短半衰期,Argatroban提供了一个安全的桥接选项.
- 在复杂的HIT案件中,个性化的DOAC使用和多学科方法对于有利的结果至关重要.
相关概念视频
Venous Thrombosis III: Interprofessional Care
257
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
257
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis IV: Nursing Management
176
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
176
Disorders of Hemostasis
1.9K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.9K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
274
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
274
Introduction to Hemostasis
13.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.0K


